Koers PhaseBio Pharmaceuticals, Inc.
Aandelen
PHAS.Q
US7172241090
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,000001 USD | 0,00% | 0,00% | 0,00% |
Omzet 2020 | 0,32 0,3 | Omzet 2021 | 10,83 10,13 | Marktkapitalisatie | 126 mln. 117 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -98 mln. -91,66 mln. | Nettowinst (verlies) 2021 | -131 mln. -123 mln. | EV/omzet 2020 | 266.368.150 x |
Nettoliquiditeiten 2020 | 13,43 mln. 12,56 mln. | Nettoliquiditeiten 2021 | 32,69 mln. 30,57 mln. | EV/omzet 2021 | 8.570.663 x |
K/w-verhouding 2020 |
-0,99
x | K/w-verhouding 2021 |
-0,87
x | Werknemers | 60 |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 99,76% |
3 maanden | -99,00% | ||
6 maanden | -99,50% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jonathan Mow
CEO | Chief Executive Officer | 59 | 04-12-12 |
Lawrence Perkins
DFI | Director of Finance/CFO | 47 | 01-10-22 |
John Lee
CTO | Chief Tech/Sci/R&D Officer | 56 | 18-04-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edmund Harrigan
BRD | Director/Board Member | 71 | 13-12-18 |
Jonathan Mow
CEO | Chief Executive Officer | 59 | 04-12-12 |
Director/Board Member | 57 | 14-09-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
0,00% | 49 | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |